Zvi Laron

15.0k total citations · 1 hit paper
399 papers, 10.5k citations indexed

About

Zvi Laron is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Zvi Laron has authored 399 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Endocrinology, Diabetes and Metabolism, 126 papers in Molecular Biology and 104 papers in Genetics. Recurrent topics in Zvi Laron's work include Growth Hormone and Insulin-like Growth Factors (237 papers), Sexual Differentiation and Disorders (48 papers) and Metabolism, Diabetes, and Cancer (45 papers). Zvi Laron is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (237 papers), Sexual Differentiation and Disorders (48 papers) and Metabolism, Diabetes, and Cancer (45 papers). Zvi Laron collaborates with scholars based in Israel, United States and Germany. Zvi Laron's co-authors include B. Klinger, A Pertzelan, Rivka Kauli, Haim Werner, Orit Shevah, A. Silbergeld, R Keret, Z Dickerman, M Karp and Raymond L. Hintz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Zvi Laron

389 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

1998 665 citations Zvi Laron et al. profile →

Peers

Countries citing papers authored by Zvi Laron

Since Specialization

Citations

This map shows the geographic impact of Zvi Laron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zvi Laron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zvi Laron more than expected).

Fields of papers citing papers by Zvi Laron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zvi Laron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zvi Laron. The network helps show where Zvi Laron may publish in the future.

Co-authorship network of co-authors of Zvi Laron

This figure shows the co-authorship network connecting the top 25 collaborators of Zvi Laron. A scholar is included among the top collaborators of Zvi Laron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zvi Laron. Zvi Laron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disabilities and Handicaps of Patients with Laron Syndrome 2025 ·Children ·Zvi Laron	0
2	Adult patients with Laron syndrome tend to develop the metabolic syndrome 2024 ·Growth Hormone & IGF Research ·Zvi Laron, Rivka Kauli, A. Silbergeld	1
3	Administration of insulin like growth factor I (IGF I) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease 2023 ·Growth Hormone & IGF Research ·Zvi Laron, Haim Werner	4
4	Laron syndrome (OMIM#262500): the Israeli cohort 60 years’ experience 2023 ·The biomedical & life sciences collection. ·Zvi Laron	0
5	Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action 2018 ·Proceedings of the National Academy of Sciences ·Karthik Nagaraj, (unknown), Rive Sarfstein, David Gurwitz, Metsada Pasmanik‐Chor, Zvi Laron, Shoshana Yakar, Haim Werner	49
6	The relationship between serum levels of prolactin and growth hormone in the early postnatal period 2017 ·Pediatric Research ·(unknown), (unknown), (unknown), (unknown), Pearl Lilos, Zvi Laron	3
7	A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000–2008 2010 ·Diabetic Medicine ·Tal Sella, (unknown), (unknown), Varda Shalev, Orit Blumenfeld, Zvi Laron, G. Chodick	32
8	Pituitary size in patients with Laron syndrome (primary GH insensitivity) 2003 ·European Journal of Endocrinology ·Liora Kornreich, Gadi Horev, Michael Schwarz, Boaz Karmazyn, Zvi Laron	16
9	Intranasally and orally active GH secretagogues are useful clinical tools: So why are they not on the market? 2003 ·Journal of Endocrinological Investigation ·Zvi Laron	2
10	Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome) 2003 ·Clinical Endocrinology ·(unknown), (unknown), Mickey Scheinowitz, (unknown), Zvi Laron	15
11	Childhood Diabetes Towards the 21st Century 1998 ·Journal of Pediatric Endocrinology and Metabolism ·Zvi Laron	7
12	Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a) 1997 ·European Journal of Endocrinology ·Zvi Laron, (unknown), B. Klinger, A. Silbergeld, D. E. L. Wilcken	38
13	Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment 1995 ·Metabolism ·Zvi Laron, Yaron Avitzur, B. Klinger	64
14	The early postnatal development of the murine mandibular condyle is regulated by endogenous insulin-like growth factor-I 1993 ·Journal of Endocrinology ·Gila Maor, Zvi Laron, (unknown), (unknown)	29
15	Effect of Octreotide on 24-Hour Growth Hormone and Prolactin Secretory Patterns in Acromegalics 1991 ·Hormone Research ·(unknown), Israel Ashkenazi, R Keret, A. Silbergeld, (unknown), Mordechai Lapidot, (unknown), Zvi Laron	2
16	Elimination Characteristics of Intravenously AdministeredrIGF-I in Laron-Type Dwarfs 1990 ·Developmental Pharmacology and Therapeutics ·B. Klinger, Moshe Garty, Zvi Laron	19
17	Clinical use of growth hormone : present and future aspects : proceedings of the Second Meeting of the International Growth and Development Association (IGDA), Taormina on Sea, May 19-22, 1986 1987 ·KARGER eBooks ·Zvi Laron, (unknown), Salvatore Raiti	2
18	Residual B cell function in diabetic children as determined by urinary C-peptide 1983 ·Diabetologia ·(unknown), (unknown), Lise G. Hedïng, M Karp, Zvi Laron	14
19	The comparative effect of 6α-fluoroprednisolone, 6α-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease 1968 ·The Journal of Pediatrics ·Zvi Laron, A Pertzelan	34
20	Activity of acid phosphatase in the cerebrospinal fluid of children 1961 ·The Journal of Pediatrics ·Zvi Laron, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact